Plenary presentation: The evolving ER+ HER2- mBC treatment landscape

101Smart Ltd.
07:50 - 08:03 Back to programme

 

Developments to address endocrine therapy resistance

 

MAT-GB-2105739 v(1.0)     

Date of Prep: January 2022

Sponsor

Speakers

Simon Lord
Consultant Medical Oncologist, Oxford University Hospitals NHS Foundation Trust